Precision Cancer Therapeutics, 2022

Description:

Precision Cancer Therapeutics, 2022 examines the current landscape of precision therapies, the significant impact they are making, and the exciting developments on the horizon. Kalorama Information has monitored the cancer treatment market for over two decades and continues to provide valuable insights into the impact of new technologies. This report is essential for understanding the expanding area of precision cancer therapies and staying informed about current products and upcoming developments.

Report Highlights:

• Global Cancer Impact:
  • Cancer continues to affect approximately 18.1 million people annually, leading to significant loss of life and financial burden.
  • Between 35 and 40 million people are living with cancer worldwide, with nearly 10 million annual deaths.
  • The most common cancers include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder.
• Precision Cancer Therapies:
  • Advanced precision cancer therapies are less invasive, less damaging, and promise improved outcomes.
  • The report focuses on five leading segments of precision therapies:
    • Monoclonal antibodies
    • Kinase inhibitors
    • Angiogenesis inhibitors
    • Proteasome inhibitors
    • CAR-T therapies
  • Additionally, smaller areas of precision therapies are covered, including mTOR inhibitors, PI3K inhibitors, PARP inhibitors, apoptosis inhibitors, histone deacetylase inhibitors, CDK inhibitors, and hedgehog signaling pathway inhibitors.

Scope and Methodology:

• Comprehensive Market Analysis:
  • The report covers precision cancer therapies that:
    • Block or turn off chemical signals that tell the cancer cell to grow and divide.
    • Change proteins within the cancer cells so the cells die.
    • Stop making new blood vessels to feed the cancer cells.
    • Trigger the immune system to kill the cancer cells.
    • Carry toxins to the cancer cells to kill them without harming normal cells.
• Detailed Statistical Information:
  • Statistical data for various types of cancers on a global level.
  • Profiles of cancers with current products available or in development, and those with significant incidence/mortality rates.
• Market Insights:
  • Overview of disease epidemiology, leading product sales, market estimates and forecasts, and a competitive summary of leading providers.
  • A list of Phase 3 precision therapies in development.
  • Discussion of market indicators, trends, and barriers.

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

Table: Cancer Treatment mAb Market, by Type, 2022-2027 (in millions $)

Source: Kalorama Information